Join the Breast Cancer - Adjuvant group to help and get support from people like you.
Breast Cancer - Adjuvant News (Page 10)
Shorter Course of Breast Cancer Radiation Won't Affect Breast Reconstruction
MONDAY, Sept. 30, 2024 – A shorter course of post-mastectomy radiation doesn't jeopardize a patient's chances of successful breast reconstruction, a new study finds. About 40 percent of people with...
Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
FRIDAY, Sept. 27, 2024 – An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer survivors, according to a study published online Sept....
Almost 200 Chemicals Linked to Breast Cancer Are Found in Food Packaging
TUESDAY, Sept. 24, 2024 – Food sold in shrink wrap, on cardboard trays or in paper containers might contain any of nearly 200 chemicals linked to breast cancer, a new study warns. Commonly used food...
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
THURSDAY, Sept. 19, 2024 – For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant...
DBT Increases Cancer Detection Versus Digital Mammography
THURSDAY, Sept. 19, 2024 – Digital breast tomosynthesis (DBT) can increase cancer detection compared with two-dimensional digital mammography (DM), according to a study published online Sept. 17 in...
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
TUESDAY, Sept. 17, 2024 – For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery calcium (CAC),...
Black Women Face Higher Death Risk From All Types of Breast Cancer
WEDNESDAY, Sept. 18, 2024 – Black women have a higher risk of dying from any type of breast cancer than white women, a new review finds. Overall, the increased survival risk for Black women ranges...
FDA Expands Use of Breast Cancer Drug Kisqali
WEDNESDAY, Sept. 18, 2024 – Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded...
Moderate Hypofractionation Shows Good Safety Outcomes in Breast Cancer
MONDAY, Sept. 16, 2024 – For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of life compared with conventional fractionation...
Breast Arterial Calcifications May Be Marker for Future Heart Disease
WEDNESDAY, Sept. 11, 2024 – Breast arterial calcifications (BAC) identified on mammography are associated with the development of both atherosclerotic cardiovascular disease (ASCVD) events and risk...
Everything You Need to Know About Breast Density, From the Experts
SATURDAY, Sept. 7, 2024 – As a new federal regulation that requires mammography centers to tell their patients how dense their breasts are takes effect, experts explain what breast density is and...
FDA Approves Genentech’s Perjeta (Pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer
South San Francisco, CA – December 20, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Perjeta ® ...
FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
July 17, 2017 – The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type...